News
LH-WI
207.45
0.00%
0.00
LABCORP AND GRAVES GILBERT CLINIC ANNOUNCE STRATEGIC AGREEMENT FOR LAB OPERATIONS
Reuters · 3d ago
LABCORP LAUNCHES H5 BIRD FLU TEST IN THE U.S., NOW AVAILABLE FOR ORDER THROUGH PHYSICIANS
Reuters · 6d ago
LABCORP: TO ACQUIRE SELECT ASSETS OF MAWD PATHOLOGY GROUP
Reuters · 12/16 12:48
LABCORP: FINALIZES ACQUISITION OF SELECT OUTREACH SERVICES FROM BALLAD HEALTH
Reuters · 12/11 13:45
LABCORP <LH.N>: JEFFERIES RAISES TARGET PRICE TO $275 FROM $265
Reuters · 12/10 08:35
OUTCOMES4ME AND LABCORP STUDY REVEALS DIGITAL EDUCATION CAN INCREASE HER2-LOW AWARENESS FOR METASTATIC BREAST CANCER PATIENTS
Reuters · 11/26 12:52
LABCORP ACQUIRES SELECT ASSETS OF LAB WORKS
Reuters · 11/20 12:49
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Reuters · 11/20 09:18
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart
Reuters · 11/20 06:56
LABCORP <LH.N>: MIZUHO RAISES TARGET PRICE TO $264 FROM $256
Reuters · 11/20 05:15
BUZZ-Labcorp falls; decade-long CFO to retire
Reuters · 11/19 13:23
LABCORP: EISENBERG WILL REMAIN AT LABCORP AS SPECIAL ADVISOR TO CEO THROUGH APRIL 2025
Reuters · 11/19 12:00
PRAIA HEALTH SECURES STRATEGIC INVESTMENT FROM LABCORP VENTURE FUND, ANNOUNCES NEW COLLABORATION TO STREAMLINE PATIENT LAB ORDERING EXPERIENCE
Reuters · 11/04 14:00
LABCORP HOLDINGS INC <LH.N>: UBS RAISES TARGET PRICE TO $293 FROM $270
Reuters · 10/25 14:53
LABCORP <LH.N>: BARCLAYS RAISES TARGET PRICE TO $249 FROM $234
Reuters · 10/25 12:07
LABCORP <LH.N>: CITIGROUP RAISES TARGET PRICE TO $250 FROM $240
Reuters · 10/25 11:05
BUZZ-U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Reuters · 10/24 18:29
Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary
Reuters · 10/24 16:25
BUZZ-U.S. STOCKS ON THE MOVE-Teck Resources, Nasdaq, T-Mobile
Reuters · 10/24 15:57
BUZZ-Labcorp rises after beating Q3 estimates
Reuters · 10/24 14:33
More
Webull provides a variety of real-time LH-WI stock news. You can receive the latest news about Laboratory Corp through multiple platforms. This information may help you make smarter investment decisions.
About LH-WI
Laboratory Corporation of America Holdings is a global life sciences company. The Company provides information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. The Company’s segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). The Dx segment is an independent clinical laboratory business. It offers a menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the United States. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services. The DD segment is a contract research organizations business that provides end-to-end drug development services. The DD segment provides these services predominantly to pharmaceutical, biotechnology and medical device companies across the world. It serves clients in more than 100 countries.